Biodegradable polymeric nanocarriers for pulmonary drug delivery

Erik Rytting, Juliane Nguyen, Xiaoying Wang, Thomas Kissel

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

Background: Pulmonary drug delivery is attractive for both local and systemic drug delivery as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood flow and the avoidance of first-pass metabolism. Objective: Nanoparticles can be designed to have several advantages for controlled and targeted drug delivery, including controlled deposition, sustained release, reduced dosing frequency, as well as an appropriate size for avoiding alveolar macrophage clearance or promoting transepithelial transport. Methods: This review focuses on the development and application of biodegradable polymers to nanocarrier-based strategies for the delivery of drugs, peptides, proteins, genes, siRNA and vaccines by the pulmonary route. Results/conclusion: The selection of natural or synthetic materials is important in designing particles or nanoparticle clusters with the desired characteristics, such as biocompatibility, size, charge, drug release and polymer degradation rate.

Original languageEnglish (US)
Pages (from-to)629-639
Number of pages11
JournalExpert Opinion on Drug Delivery
Volume5
Issue number6
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Lung
Pharmaceutical Preparations
Nanoparticles
Polymers
Genetic Selection
Alveolar Macrophages
Small Interfering RNA
Vaccines
Peptides
Proteins
Drug Liberation

Keywords

  • Biodegradable polymers
  • Gene and siRNA delivery
  • Nanoparticles
  • Peptides
  • Proteins
  • Pulmonary drug delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Biodegradable polymeric nanocarriers for pulmonary drug delivery. / Rytting, Erik; Nguyen, Juliane; Wang, Xiaoying; Kissel, Thomas.

In: Expert Opinion on Drug Delivery, Vol. 5, No. 6, 06.2008, p. 629-639.

Research output: Contribution to journalArticle

Rytting, Erik ; Nguyen, Juliane ; Wang, Xiaoying ; Kissel, Thomas. / Biodegradable polymeric nanocarriers for pulmonary drug delivery. In: Expert Opinion on Drug Delivery. 2008 ; Vol. 5, No. 6. pp. 629-639.
@article{a363f30bd72b4530abde1aaf0a1df59f,
title = "Biodegradable polymeric nanocarriers for pulmonary drug delivery",
abstract = "Background: Pulmonary drug delivery is attractive for both local and systemic drug delivery as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood flow and the avoidance of first-pass metabolism. Objective: Nanoparticles can be designed to have several advantages for controlled and targeted drug delivery, including controlled deposition, sustained release, reduced dosing frequency, as well as an appropriate size for avoiding alveolar macrophage clearance or promoting transepithelial transport. Methods: This review focuses on the development and application of biodegradable polymers to nanocarrier-based strategies for the delivery of drugs, peptides, proteins, genes, siRNA and vaccines by the pulmonary route. Results/conclusion: The selection of natural or synthetic materials is important in designing particles or nanoparticle clusters with the desired characteristics, such as biocompatibility, size, charge, drug release and polymer degradation rate.",
keywords = "Biodegradable polymers, Gene and siRNA delivery, Nanoparticles, Peptides, Proteins, Pulmonary drug delivery",
author = "Erik Rytting and Juliane Nguyen and Xiaoying Wang and Thomas Kissel",
year = "2008",
month = "6",
doi = "10.1517/17425247.5.6.629",
language = "English (US)",
volume = "5",
pages = "629--639",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Biodegradable polymeric nanocarriers for pulmonary drug delivery

AU - Rytting, Erik

AU - Nguyen, Juliane

AU - Wang, Xiaoying

AU - Kissel, Thomas

PY - 2008/6

Y1 - 2008/6

N2 - Background: Pulmonary drug delivery is attractive for both local and systemic drug delivery as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood flow and the avoidance of first-pass metabolism. Objective: Nanoparticles can be designed to have several advantages for controlled and targeted drug delivery, including controlled deposition, sustained release, reduced dosing frequency, as well as an appropriate size for avoiding alveolar macrophage clearance or promoting transepithelial transport. Methods: This review focuses on the development and application of biodegradable polymers to nanocarrier-based strategies for the delivery of drugs, peptides, proteins, genes, siRNA and vaccines by the pulmonary route. Results/conclusion: The selection of natural or synthetic materials is important in designing particles or nanoparticle clusters with the desired characteristics, such as biocompatibility, size, charge, drug release and polymer degradation rate.

AB - Background: Pulmonary drug delivery is attractive for both local and systemic drug delivery as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood flow and the avoidance of first-pass metabolism. Objective: Nanoparticles can be designed to have several advantages for controlled and targeted drug delivery, including controlled deposition, sustained release, reduced dosing frequency, as well as an appropriate size for avoiding alveolar macrophage clearance or promoting transepithelial transport. Methods: This review focuses on the development and application of biodegradable polymers to nanocarrier-based strategies for the delivery of drugs, peptides, proteins, genes, siRNA and vaccines by the pulmonary route. Results/conclusion: The selection of natural or synthetic materials is important in designing particles or nanoparticle clusters with the desired characteristics, such as biocompatibility, size, charge, drug release and polymer degradation rate.

KW - Biodegradable polymers

KW - Gene and siRNA delivery

KW - Nanoparticles

KW - Peptides

KW - Proteins

KW - Pulmonary drug delivery

UR - http://www.scopus.com/inward/record.url?scp=47349122617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47349122617&partnerID=8YFLogxK

U2 - 10.1517/17425247.5.6.629

DO - 10.1517/17425247.5.6.629

M3 - Article

VL - 5

SP - 629

EP - 639

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 6

ER -